首页> 外文学位 >Application of cysteine scanning mutagenesis to the multidrug resistance protein (MRP)1.
【24h】

Application of cysteine scanning mutagenesis to the multidrug resistance protein (MRP)1.

机译:半胱氨酸扫描诱变在多药耐药蛋白(MRP)中的应用1。

获取原文
获取原文并翻译 | 示例

摘要

Multidrug resistance protein (MRP)1, a member of the ABCC branch of the ATP-binding cassette (ABC) superfamily of transporters, can confer resistance to a broad spectrum of chemotherapeutic agents. In addition to the core functional unit of ABC transporters that consists of two membrane spanning domains (MSD) and two nucleotide binding domains (NBD), MRP1 contains a third MSD (MSD0) resulting in the following arrangement: NH2-MSD-(MSD-NBD) 2. In lieu of high-resolution structural information for MRP1, cysteine scanning mutagenesis (CSM) was applied to MRP1 and involves the development of a functional template devoid of cysteines into which paired cysteines can be introduced. Previous attempts to create a functional, cys-less template of MRP1 demonstrated that cysteines in MSD0 were structurally and functional important (1;2). However, given that MRP1 lacking MSD0 remains functional, a partially functional, cys-less MRP1 lacking this domain has been expressed in yeast (3-5). Given these results, with the ultimate goal of applying CSM to MRP1 in its entirety, we investigated the endogenous cysteines within MSD0 and co-expressed MRP1 half-molecules and validated these potential CSM templates by transport and ATP binding/hydrolysis assays. Mutation of cysteines within the core of MRP1 had detrimental effects on MRP1 transport activity and further mutation of cysteines by domain revealed that wild-type activity was retained in an MSD0-less MRP1 dual lacking cysteines in both NBDs. This construct was used for introduction of cysteines on juxtaposed faces of the NBD1:NBD2 heterodimer at positions 775 and 1329; comparable residues in the related Cystic Fibrosis Transmembrane Regulator (CFTR/ABCC7) have been suggested to be evolutionarily coupled and joined by a hydrogen bond, maintained in structures of related proteins (6). Unfortunately, functional assays revealed that introduction of cysteines at these positions greatly reduced transport activity of MRP1 and diminished trapping of nucleotide at both NBDs. Finally, alanine substitution of the seven cysteines in MSD0 was not without effect and cellular trafficking assays, co-expression studies and SDS-PAGE analysis suggested an altered conformation of this domain. In addition, a disulfide pair of Cys7 and Cys32 was suggested by these experiments in MSD0 and further supported by examination of these mutants in full-length MRP1.
机译:多药耐药蛋白(MRP)1是转运蛋白ATP结合盒(ABC)超家族的ABCC分支的成员,可以赋予广泛的化疗药物耐药性。除了由两个跨膜结构域(MSD)和两个核苷酸结合结构域(NBD)组成的ABC转运蛋白的核心功能单元外,MRP1还包含第三个MSD(MSD0),其结构如下:NH2-MSD-(MSD- NBD)2.代替MRP1的高分辨率结构信息,将半胱氨酸扫描诱变(CSM)应用于MRP1,涉及开发不含半胱氨酸的功能模板,可以将成对的半胱氨酸引入其中。先前尝试创建MRP1的功能性半胱氨酸模板的尝试表明,MSD0中的半胱氨酸在结构和功能上很重要(1; 2)。但是,考虑到缺少MSD0的MRP1仍具有功能,因此在酵母中已表达了缺少该结构域的部分功能,少半胱氨酸的MRP1(3-5)。给出这些结果,最终目的是将CSM整体应用于MRP1,我们研究了MSD0中的内源性半胱氨酸和共表达的MRP1半分子,并通过转运和ATP结合/水解试验验证了这些潜在的CSM模板。 MRP1核心内的半胱氨酸突变对MRP1转运活性具有有害影响,半胱氨酸按域的进一步突变表明,野生型活性保留在两个NBD中均缺少MSD0的缺少MRP1的双重缺乏半胱氨酸中。该构建体用于在位点775和1329的NBD1:NBD2异二聚体的并置面上引入半胱氨酸。相关囊性纤维化跨膜调节剂(CFTR / ABCC7)中的可比残基已被建议通过维持相关蛋白结构中的氢键进行进化偶联和结合(6)。不幸的是,功能分析表明,在这些位置引入半胱氨酸大大降低了MRP1的转运活性,并减少了两个NBD处的核苷酸捕获。最后,MSD0中的七个半胱氨酸的丙氨酸取代并非没有效果,细胞运输测定,共表达研究和SDS-PAGE分析表明该结构域的构象发生了改变。此外,这些实验在MSD0中提出了Cys7和Cys32的二硫键对,并通过在全长MRP1中检查这些突变体进一步支持。

著录项

  • 作者

    Theis, Ashley Rebecca.;

  • 作者单位

    Queen's University (Canada).;

  • 授予单位 Queen's University (Canada).;
  • 学科 Biology Molecular.
  • 学位 M.Sc.
  • 年度 2009
  • 页码 154 p.
  • 总页数 154
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子遗传学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号